How much cash does Oric Pharmaceuticals, Inc. generate?

Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.

What is Oric Pharmaceuticals, Inc.'s free cash flow?

After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.

Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?

Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Oric Pharmaceuticals, Inc. ORIC Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$135.21M-4.4%	-$129.47M+4.3%	-$135.27M+1.4%	-$137.25M-3.3%	-$132.86M-3.9%
Depreciation and amortization	$1.19M-2.6%	$1.22M+1.3%	$1.2M+1.5%	$1.19M+3.3%	$1.15M+3.7%
Stock-based compensation	$25.38M+1.4%	$25.04M+4.5%	$23.96M+2.5%	$23.39M+7.2%	$21.81M+7.9%
Change in accounts payable	——	——	——	——	——
Change in other assets	-$1.68M+5.8%	-$1.79M-73.7%	-$1.03M+45.2%	-$1.88M+5.0%	-$1.98M-1,283%
Net cash from operating activities	-$110.88M+0.1%	-$110.97M+4.8%	-$116.54M+3.1%	-$120.23M-4.5%	-$115.01M-2.1%
Capital expenditures	$327K-54.1%	$712K+1.1%	$704K-35.2%	$1.09M-19.9%	$1.36M+14.2%
Purchases of investments	$413.13M+3.3%	$399.82M+2.7%	$389.16M+40.2%	$277.67M+37.3%	$202.19M-19.7%
Net cash from investing activities	——	——	-$122.36M—	——	——
Proceeds from issuance of common stock	$305.25M+24.9%	$244.37M—	——	——	——
Net cash from financing activities	$306.39M+24.9%	$245.26M+0.4%	$244.34M+81.0%	$135.01M+8,736%	$1.53M-98.8%
Net increase (decrease) in cash	$7.06M+151%	-$13.74M-353%	$5.44M—	——	——
Accretion (Amortization) of Discounts and Premiums, Investments	$1.26M-45.4%	$2.3M-37.7%	$3.69M-26.9%	$5.05M-25.2%	$6.76M-16.6%
Depreciation	$1.19M-2.6%	$1.22M+1.3%	$1.2M+1.5%	$1.19M+3.3%	$1.15M+3.7%
Increase (Decrease) in Prepaid Expense and Other Assets	-$1.68M+5.8%	-$1.79M-73.7%	-$1.03M+45.2%	-$1.88M+5.0%	-$1.98M-1,283%
Payment Of Deferred Issuance Costs	——	——	——	——	——
Payments Of Stock Issuance Costs	$3.39M+41.4%	$2.4M—	——	——	——
Free cash flow	-$111.2M+0.4%	-$111.68M+4.7%	-$117.25M+3.4%	-$121.31M-4.3%	-$116.37M-2.2%
Free cash flow	-$111.2M+0.4%	-$111.68M+4.7%	-$117.25M+3.4%	-$121.31M-4.3%	-$116.37M-2.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Oric Pharmaceuticals, Inc. generate?: Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
What is Oric Pharmaceuticals, Inc.'s free cash flow?: After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?: Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.